Group One Trading, L.P. Morphic Holding, Inc. Transaction History

Group One Trading, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$26.12 - $34.07 $205,642 - $268,233	7,873 New	7,873 $268,000
Q2 2023 Aug 09, 2023	SELL	$34.33 - $62.11 $62,789 - $113,599	-1,829 Reduced 76.88%	550 $31,000
Q1 2023 May 12, 2023	BUY	$26.01 - $48.69 $61,877 - $115,833	2,379 New	2,379 $89,000
Q2 2022 Aug 11, 2022	SELL	$19.74 - $43.01 $27,635 - $60,214	-1,400 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$36.25 - $52.02 $50,750 - $72,828	1,400 New	1,400 $56,000

4.7M

Ticker MORF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,477,100
Market Cap $2.19B
Description
Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.